The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126067521 12606752 1 I 20160404 20160722 20160729 20160729 EXP FR-009507513-1607FRA010851 MERCK 70.28 YR M Y 66.00000 KG 20160729 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126067521 12606752 1 PS VIRAFERONPEG PEGINTERFERON ALFA-2B 1 120 MICROGRAM, QW 5280 UG 103949 120 UG POWDER FOR INJECTION /wk
126067521 12606752 2 SS INTERFERON ALFA-2B INTERFERON ALFA-2B 1 THREE TIMES PER WEEK 0 POWDER FOR INJECTION
126067521 12606752 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral 200 MG, 5 TIMES PER DAY 413000 MG 0 200 MG TABLET
126067521 12606752 4 SS REBETOL RIBAVIRIN 1 Oral UNK 0 CAPSULE
126067521 12606752 5 SS PEGASYS PEGINTERFERON ALFA-2A 1 UNK 0
126067521 12606752 6 SS COPEGUS RIBAVIRIN 1 UNK 0
126067521 12606752 7 C LEVOTHYROXINE SODIUM. LEVOTHYROXINE SODIUM 1 Oral 125 MICROGRAM, QD 0 125 UG TABLET QD
126067521 12606752 8 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 1 G, BID 0 1 G BID
126067521 12606752 9 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 3.5 MG, QD 0 3.5 MG QD
126067521 12606752 10 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 4 MG, UNK 0 4 MG
126067521 12606752 11 C ROVALCYTE VALGANCICLOVIR HYDROCHLORIDE 1 Oral 1 DF, BID 0 1 DF TABLET BID
126067521 12606752 12 C CORTANCYL PREDNISONE 1 15 MG, QD 0 15 MG QD
126067521 12606752 13 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 0.5 DF, 3 TIMES PER WEEK 0 .5 DF TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126067521 12606752 1 Hepatitis C
126067521 12606752 2 Hepatitis C
126067521 12606752 3 Hepatitis C
126067521 12606752 4 Hepatitis C
126067521 12606752 5 Hepatitis C
126067521 12606752 6 Hepatitis C
126067521 12606752 7 Hypothyroidism
126067521 12606752 8 Prophylaxis against transplant rejection
126067521 12606752 9 Prophylaxis against transplant rejection
126067521 12606752 11 Infection prophylaxis
126067521 12606752 13 Infection

Outcome of event

Event ID CASEID OUTC COD
126067521 12606752 OT
126067521 12606752 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126067521 12606752 Biloma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126067521 12606752 1 20020215 20021212 0
126067521 12606752 2 19981201 20000117 0
126067521 12606752 3 19981201 20000117 0
126067521 12606752 4 20020215 20021212 0
126067521 12606752 5 20050905 20070322 0
126067521 12606752 6 20050905 20070322 0
126067521 12606752 7 20020704 0
126067521 12606752 8 20160315 0
126067521 12606752 9 20160315 0
126067521 12606752 10 20160315 0
126067521 12606752 11 20160315 0
126067521 12606752 12 20160323 0
126067521 12606752 13 20160315 0